![](/img/cover-not-exists.png)
Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a named patient programme (NPP)
Fröbe, Ana, Murgić, Jure, Rauh, StefanVolume:
1
Language:
english
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2016-000049
Date:
May, 2016
File:
PDF, 463 KB
english, 2016